Deutsche Bank’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-159,086
| Closed | -$12.7M | – | 4989 |
|
|
2021
Q1 | $12.7M | Buy |
159,086
+127,969
| +411% | +$9.99M | 0.01% | 1078 |
|
|
2020
Q4 | $2.45M | Buy |
31,117
+7,023
| +29% | +$412K | ﹤0.01% | 1805 |
|
|
2020
Q3 | $1.06M | Sell |
24,094
-15,397
| -39% | -$759K | ﹤0.01% | 2158 |
|
|
2020
Q2 | $1.75M | Sell |
39,491
-61,786
| -61% | -$2.31M | ﹤0.01% | 1886 |
|
|
2020
Q1 | $3.63M | Buy |
101,277
+100,292
| +10,182% | +$5.7M | ﹤0.01% | 1420 |
|
|
2019
Q4 | $69K | Sell |
985
-2,496
| -72% | -$181K | ﹤0.01% | 3783 |
|
|
2019
Q3 | $258K | Sell |
3,481
-7,292
| -68% | -$618K | ﹤0.01% | 3037 |
|
|
2019
Q2 | $865K | Sell |
10,773
-32,450
| -75% | -$2.28M | ﹤0.01% | 2933 |
|
|
2019
Q1 | $2.89M | Sell |
43,223
-54,869
| -56% | -$4.16M | ﹤0.01% | 2231 |
|
|
2018
Q4 | $7.3M | Sell |
98,092
-23,414
| -19% | -$1.93M | 0.01% | 1506 |
|
|
2018
Q3 | $11.2M | Buy |
121,506
+10,403
| +9% | +$991K | 0.01% | 1551 |
|
|
2018
Q2 | $10.9M | Buy |
111,103
+27,504
| +33% | +$3.08M | 0.01% | 1664 |
|
|
2018
Q1 | $9.31M | Buy |
83,599
+2,692
| +3% | +$302K | ﹤0.01% | 1678 |
|
|
2017
Q4 | $8.32M | Buy |
80,907
+48,247
| +148% | +$4.81M | 0.01% | 1639 |
|
|
2017
Q3 | $3.07M | Sell |
32,660
-13,956
| -30% | -$1.1M | ﹤0.01% | 2239 |
|
|
2017
Q2 | $3.63M | Buy |
46,616
+37,560
| +415% | +$2.82M | ﹤0.01% | 2152 |
|
|
2017
Q1 | $724K | Sell |
9,056
-15,540
| -63% | -$1.23M | ﹤0.01% | 2861 |
|
|
2016
Q4 | $1.94M | Sell |
24,596
-26,588
| -52% | -$2.07M | ﹤0.01% | 2280 |
|
|
2016
Q3 | $3.99M | Buy |
51,184
+4,072
| +9% | +$295K | ﹤0.01% | 1891 |
|
|
2016
Q2 | $3.24M | Sell |
47,112
-12,238
| -21% | -$844K | ﹤0.01% | 2063 |
|
|
2016
Q1 | $4.23M | Sell |
59,350
-6,804
| -10% | -$427K | ﹤0.01% | 1856 |
|
|
2015
Q4 | $4.11M | Sell |
66,154
-12,492
| -16% | -$762K | ﹤0.01% | 1928 |
|
|
2015
Q3 | $4.46M | Buy |
78,646
+17,854
| +29% | +$945K | ﹤0.01% | 1891 |
|
|
2015
Q2 | $3.26M | Sell |
60,792
-2,193
| -3% | -$107K | ﹤0.01% | 2101 |
|
|
2015
Q1 | $2.99M | Sell |
62,985
-8,976
| -12% | -$397K | ﹤0.01% | 2160 |
|
|
2014
Q4 | $3.11M | Buy |
71,961
+18,139
| +34% | +$741K | ﹤0.01% | 2327 |
|
|
2014
Q3 | $1.85M | Buy |
53,822
+23,378
| +77% | +$826K | ﹤0.01% | 2573 |
|
|
2014
Q2 | $1.11M | Buy |
30,444
+1,474
| +5% | +$50K | ﹤0.01% | 2861 |
|
|
2014
Q1 | $976K | Buy |
28,970
+7,294
| +34% | +$241K | ﹤0.01% | 2875 |
|
|
2013
Q4 | $734K | Sell |
21,676
-32,125
| -60% | -$1.11M | ﹤0.01% | 2843 |
|
|
2013
Q3 | $1.71M | Buy |
53,801
+20,094
| +60% | +$534K | ﹤0.01% | 2580 |
|
|
2013
Q2 | $760K | Buy |
+33,707
| New | +$730K | ﹤0.01% | 2883 |
|
Deutsche Bank's CMD Position: Q2 2021 in Review
Deutsche Bank sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 159,086 shares — an estimated $12.7M sold.
Deutsche Bank first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $12.7M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Deutsche Bank reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Deutsche Bank sold 159,086 Cantel Medical Corporation shares in Q2 2021, an estimated $12.7M.
- Deutsche Bank first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Deutsche Bank's Cantel Medical Corporation position peaked at $12.7M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.